NEW YORK and HERTZLIYA, Israel — InterCure Ltd. will effect a one-for-five reverse split of the company’s ordinary shares, no par value per share. The ordinary shares will continue to trade on the Nasdaq Global Market under the existing symbol INCR and will begin trading on a split-adjusted basis when the market opens on August 24, 2026. The new CUSIP number for the ordinary shares following the consolidation will be M549GJ368. The primary purpo…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.